查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1829828

2025年全球疫苗注射设备市场报告

Vaccine Delivery Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，疫苗注射装置市场规模强劲成长，从2024年的63.9亿美元增加至2025年的70.1亿美元，复合年增长率为9.7%。预测期内的成长可归因于大规模脊髓灰质炎疫苗接种宣传活动、扩大免疫规划 (EPI)、一次性注射器的普及、天花根除工作、全球疫苗免疫联盟 (GAVI) 以及疫苗联盟等措施。

预计未来几年疫苗注射装置市场规模将强劲成长，到2029年将达到101亿美元，复合年增长率为9.5%。预测期内的增长可归因于对免疫接种计划的日益重视、疫苗开发平臺的拓展、儿科和老年人口的增长、对低温运输管理的日益重视以及对预防性医疗保健措施重要性的日益认识。预测期内的主要趋势包括疫苗注射装置技术的持续创新、对无针解决方案的关注、个人化医疗的进步、新型自主接种疫苗以及伙伴关係的建立。

疫苗输送装置是为安全有效地向个人注射疫苗而设计的机製或系统。这些精密设计的工具可确保剂量精准、输送精准，并最大程度地减少接种者的不适。这些工具在公共卫生领域的重要性在于它们能够促进疫苗的分发和应用，并阻止感染疾病的传播。

疫苗给药装置的主要类别包括无针注射系统、口服给药系统、鼻腔给药系统、喷射注射器、微针贴片和微注射器。无针注射系统是一种无需使用传统针头即可将药物注射到皮肤中的医疗器械。它们支持多种给药途径，包括皮内、肌肉注射和皮下接种，并被包括医院和诊所在内的各种终端使用者所使用。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供疫苗输送装置市场统计数据，例如全球市场规模、区域份额、疫苗输送装置市场份额的竞争对手、详细的疫苗输送装置细分市场、市场趋势以及疫苗输送装置行业的商机。这些疫苗输送装置市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切资讯的完整展望。

我们预测未来五年该市场将成长9.5%，较我们先前对该市场的预测略有下降0.6%。下降的主要原因是美国与其他国家之间关税的影响。这可能会直接影响美国，导致来自日本和瑞士等主要地区的微针阵列贴片和自毁式註射器的供应链中断，从而导致疫苗接种延迟和疫苗接种计划成本增加。由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，影响可能会更加广泛。

感染疾病的日益普及推动了疫苗输送装置市场的扩张。感染疾病由各种微生物引起，包括细菌、病毒、真菌和寄生虫，并透过各种方式传播，包括人与人之间的接触、动物、媒介和污染物。导致感染疾病传播的因素包括全球旅行增加、快速都市化、气候变迁和人口成长。疫苗输送装置透过有效地为人群接种疫苗、增强免疫力和抑制感染率在疾病预防中发挥着至关重要的作用。例如，根据世界卫生组织 (WHO) 2023 年 11 月的报告，2022 年全球报告了约 1,060 万例结核病，影响了 580 万名男性、350 万名女性和 130 万名儿童。因此，感染疾病的传播正在支持疫苗输送装置市场的成长。

疫苗输送装置领域的主要企业正在透过推出预灌封注射器等产品进行创新，以提高疫苗输送的有效性和安全性。预灌封注射器旨在安全地容纳和分配预定剂量的药物（通常为液体形式），专门用于疫苗。例如，2022年9月，美国医疗科技公司碧迪（BD）推出了BD Effivax玻璃预灌封注射器。这种先进的疫苗输送装置旨在透过提高疫苗接种的可靠性和效率来满足疫苗生产不断变化的需求。此註射器采用增强技术和更严格的规格，以提高填充/完成的可靠性和容器耐用性，从而降低生产中断的风险并提高生产能力。

2022年1月，总部位于美国的输液治疗用尖端医疗设备製造商ICU Medical以未披露的金额从史密斯集团手中收购了史密斯医疗。此次收购旨在将注射器、门诊输液设备、血管通路工具和基本护理产品整合到ICU Medical的产品组合中。史密斯医疗总部位于美国，专注于疫苗输送设备。

疫苗输送装置市场的主要参与者包括辉瑞、强生、默克公司、赛诺菲公司、赛诺菲公司、诺华国际股份公司、阿斯特捷利康公司、3M 公司、葛兰素史克公司、Moderna 公司、碧迪公司 (BD)、科兴生物技术有限公司、CSL 有限公司、INOVIO 公司、Terumo Corporation 、CSL 有限公司、BVrian Adici， Corporation、康希诺生物股份公司、Vaxxas 公司、PharmaJet 公司、Enesi Pharma 有限公司、NanoPass Technologies 有限公司、Gerresheimer 股份公司和 Panacea Biotec 有限公司。

2024年，北美是疫苗输送装置市场最大的地区。预计亚太地区将成为预测期内成长最快的地区。疫苗输送装置市场报告涵盖亚太地区、西欧、中欧和东欧、北美、南美以及中东和非洲。

疫苗注射装置市场报告涵盖的国家有澳洲、巴西、中国、法国、德国、印度、印尼、日本、美国、韩国、英国、英国、加拿大、义大利和西班牙。

疫苗输送装置市场包括喷射注射器、自动注射器、口服疫苗输送装置、微针贴片、经皮吸收贴片、吸入器和皮内注射装置的销售。该市场的价值为“出厂价”，即商品製造商或生产商向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的商品价值。该市场中的商品价值还包括商品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球疫苗接种设备：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球疫苗输送装置市场：成长率分析
  • 全球疫苗注射装置市场表现：规模与成长，2019-2024
  • 全球疫苗注射装置市场预测：规模与成长，2024-2029 年，2034 年
  • 全球疫苗接种设备：总目标市场（TAM）

第六章 市场细分

  • 全球疫苗注射设备市场（依设备类型、实际及预测），2019-2024 年、2024-2029 年、2034 年
  • 无针注射系统
  • 口服给药系统
  • 鼻腔给药系统
  • 喷射注射器
  • 微针贴片和微注射器
  • 全球疫苗注射装置市场（依给药途径）：2019-2024 年、2024-2029 年、2034 年实际资料及预测
  • 皮内接种
  • 肌肉注射疫苗
  • 皮下接种
  • 其他疫苗
  • 全球疫苗注射装置市场：按最终用户、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 诊所
  • 其他最终用户
  • 全球疫苗注射装置市场：按无针注射系统细分（按类型）、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 基于 Spring 的注入器
  • 气动喷射器
  • 混合喷油器
  • 全球疫苗给药装置市场：按口服给药系统细分（按类型）、实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 口服片剂和胶囊
  • 口腔喷雾剂
  • 口服溶液
  • 全球疫苗给药装置市场：依鼻腔给药系统细分（按类型）、实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 鼻喷剂
  • 滴鼻剂
  • 鼻粉系统
  • 全球疫苗输送装置市场：喷射注射器细分市场（按类型）、实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 气动喷射注射器
  • 电子机械喷射注射器
  • 全球疫苗输送装置市场：按类型细分：微针贴片和微注射器，实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 可溶解微针
  • 实心微针
  • 显微注射装置

第七章 区域和国家分析

  • 全球疫苗注射装置市场：区域分析、预测与成长，2019-2024 年、2024-2029 年、2034 年
  • 全球疫苗注射装置市场：国家、现况及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 疫苗输送装置市场：竞争格局
  • 疫苗输送装置市场：公司简介
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
    • Novartis International AG Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • AstraZeneca PLC
  • 3M Company
  • GlaxoSmithKline plc
  • Moderna Inc.
  • Becton Dickinson and Company（BD）
  • Sinovac Biotech Co. Ltd.
  • CSL Limited
  • INOVIO Pharmaceuticals Inc.
  • Terumo Corporation
  • SCHOTT AG
  • Serum Institute of India Pvt. Ltd.
  • Bavarian Nordic A/S
  • Dynavax Technologies Corporation
  • CanSino Biologics Inc.
  • Vaxxas Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年疫苗注射装置市场：提供新机会的国家
  • 2029年疫苗注射装置市场：细分市场将带来新机会
  • 2029年疫苗注射设备市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r31459u

Vaccine delivery devices are mechanisms or systems devised to safely and efficiently administer vaccines to individuals. Engineered with precision, these tools guarantee precise dosage, accurate delivery, and minimal discomfort for the recipient. Their significance in public health endeavors lies in their ability to facilitate the distribution and application of vaccines, thereby thwarting the spread of infectious diseases.

The primary categories of vaccine delivery devices comprise needle-free injection systems, oral delivery systems, nasal delivery systems, jet injectors, microneedle patches, and microinjectors. Needle-free injection systems are medical tools designed to administer medication into the skin without employing a conventional needle. They facilitate various routes of administration, including intradermal, intramuscular, and subcutaneous vaccination, and are utilized by a range of end-users, including hospitals and clinics.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The vaccine delivery devices market research report is one of a series of new reports from The Business Research Company that provides vaccine delivery devices market statistics, including the vaccine delivery devices industry global market size, regional shares, competitors with vaccine delivery devices market share, detailed vaccine delivery devices market segments, market trends, and opportunities, and any further data you may need to thrive in the vaccine delivery devices industry. These vaccine delivery devices market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The vaccine delivery devices market size has grown strongly in recent years. It will grow from $6.39 billion in 2024 to $7.01 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to large-scale polio vaccination campaigns, expanded program on immunization (EPI), the adoption of disposable syringes, smallpox eradication efforts, initiatives including the global alliance for vaccines and immunization (GAVI) and the vaccine alliance.

The vaccine delivery devices market size is expected to see strong growth in the next few years. It will grow to $10.1 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to the growing emphasis on immunization programs, expanded vaccine development pipelines, expanding pediatric and geriatric populations, focus on cold chain management, and raising awareness about the importance of preventive healthcare measures. Major trends in the forecast period include the continued innovations in vaccine delivery device technology, focus on needle-free solutions, advancements in personalized medicine, new self-administered vaccines, and the partnerships.

The forecast of 9.5% growth over the next five years reflects a modest reduction of 0.6% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for microneedle array patches and auto-disable syringe mechanisms, sourced from key regions such as Japan and Switzerland, could lead to immunization delays and higher vaccination program costs.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rise in infectious diseases prevalence is poised to drive the expansion of the vaccine delivery devices market. Infectious diseases, caused by various microorganisms such as bacteria, viruses, fungi, or parasites, spread through various means including person-to-person contact, animals, vectors, or contaminated substances. Factors contributing to the prevalence of infectious diseases include increased global travel, rapid urbanization, shifts in climate patterns, and population expansion. Vaccine delivery devices play a pivotal role in disease prevention by effectively administering vaccines to populations, bolstering immunity, and curbing transmission rates. For instance, as reported by the World Health Organization (WHO) in November 2023, approximately 10.6 million cases of tuberculosis (TB) were reported worldwide in 2022, impacting 5.8 million men, 3.5 million women, and 1.3 million children. Consequently, the pervasive presence of infectious diseases underpins the growth of the vaccine delivery devices market.

Major companies in the vaccine delivery devices sector are innovating by introducing products such as prefillable syringes to improve the effectiveness and safety of vaccine delivery. Prefillable syringes are designed to securely contain and dispense a predetermined dosage of medication, typically in liquid form, specifically for vaccines. For example, in September 2022, Becton, Dickinson, and Company (BD), a US-based medical technology firm, launched the BD Effivax Glass Prefillable Syringe. This advanced vaccine delivery device aims to address the evolving requirements of vaccine production by enhancing reliability and efficiency in vaccine administration. The syringe incorporates enhanced technology and stricter specifications to provide increased fill or finish reliability and container durability, thereby reducing the risk of production interruptions and enhancing manufacturing capabilities.

In January 2022, ICU Medical Inc., a US-based producer of cutting-edge medical equipment utilized in infusion therapy, purchased Smiths Medical from Smiths Group plc for an undisclosed sum. This acquisition was aimed at integrating syringe and ambulatory infusion devices, vascular access tools, and essential care products into ICU Medical's range. Smiths Medical, a US-based company, specializes in vaccine delivery devices.

Major companies operating in the vaccine delivery devices market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., Novartis International AG, AstraZeneca PLC, 3M Company, GlaxoSmithKline plc, Moderna Inc., Becton Dickinson and Company (BD), Sinovac Biotech Co. Ltd., CSL Limited, INOVIO Pharmaceuticals Inc., Terumo Corporation, SCHOTT AG, Serum Institute of India Pvt. Ltd., Bavarian Nordic A/S, Dynavax Technologies Corporation, CanSino Biologics Inc., Vaxxas Inc., PharmaJet Inc., Enesi Pharma Limited, NanoPass Technologies Ltd., Gerresheimer AG, Panacea Biotec Limited

North America was the largest region in the vaccine delivery devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vaccine delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the vaccine delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The vaccine delivery devices market consists of sales of jet injectors, auto-injectors, oral vaccine delivery, microneedle patches, transdermal patches, inhalers, and intradermal devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Vaccine Delivery Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on vaccine delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for vaccine delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The vaccine delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type Of Device: Needle Free Injection Systems; Oral Delivery Systems; Nasal Delivery Systems; Jet Injectors; Microneedle Patches And Microinjectors
  • 2) By Route Of Administration: Intradermal Vaccination; Intramuscular Vaccination; Subcutaneous Vaccination; Other Vaccinations
  • 3) By End Users: Hospitals; Clinics; Other End Users
  • Subsegments:
  • 1) By Needle Free Injection Systems: Spring-Based Injectors; Gas-Driven Injectors; Hybrid Injectors
  • 2) By Oral Delivery Systems: Oral Tablets And Capsules; Oral Sprays; Oral Solutions
  • 3) By Nasal Delivery Systems: Nasal Sprays; Nasal Drops; Nasal Powder Systems
  • 4) By Jet Injectors: Pneumatic Jet Injectors; Electromechanical Jet Injectors
  • 5) By Microneedle Patches And Microinjectors: Dissolvable Microneedles; Solid Microneedles; Microinjector Devices
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Merck & Co. Inc.; Sanofi S.A.; Novartis International AG; AstraZeneca PLC; 3M Company; GlaxoSmithKline plc; Moderna Inc.; Becton Dickinson and Company (BD); Sinovac Biotech Co. Ltd.; CSL Limited; INOVIO Pharmaceuticals Inc.; Terumo Corporation; SCHOTT AG; Serum Institute of India Pvt. Ltd.; Bavarian Nordic A/S; Dynavax Technologies Corporation; CanSino Biologics Inc.; Vaxxas Inc.; PharmaJet Inc.; Enesi Pharma Limited; NanoPass Technologies Ltd.; Gerresheimer AG; Panacea Biotec Limited
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Vaccine Delivery Devices Market Characteristics

3. Vaccine Delivery Devices Market Trends And Strategies

4. Vaccine Delivery Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Vaccine Delivery Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Vaccine Delivery Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Vaccine Delivery Devices Market Growth Rate Analysis
  • 5.4. Global Vaccine Delivery Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Vaccine Delivery Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Vaccine Delivery Devices Total Addressable Market (TAM)

6. Vaccine Delivery Devices Market Segmentation

  • 6.1. Global Vaccine Delivery Devices Market, Segmentation By Type Of Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Needle Free Injection Systems
  • Oral Delivery Systems
  • Nasal Delivery Systems
  • Jet Injectors
  • Microneedle Patches And Microinjectors
  • 6.2. Global Vaccine Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Intradermal Vaccination
  • Intramuscular Vaccination
  • Subcutaneous Vaccination
  • Other Vaccinations
  • 6.3. Global Vaccine Delivery Devices Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Other End Users
  • 6.4. Global Vaccine Delivery Devices Market, Sub-Segmentation Of Needle Free Injection Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Spring-Based Injectors
  • Gas-Driven Injectors
  • Hybrid Injectors
  • 6.5. Global Vaccine Delivery Devices Market, Sub-Segmentation Of Oral Delivery Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral Tablets And Capsules
  • Oral Sprays
  • Oral Solutions
  • 6.6. Global Vaccine Delivery Devices Market, Sub-Segmentation Of Nasal Delivery Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Nasal Sprays
  • Nasal Drops
  • Nasal Powder Systems
  • 6.7. Global Vaccine Delivery Devices Market, Sub-Segmentation Of Jet Injectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pneumatic Jet Injectors
  • Electromechanical Jet Injectors
  • 6.8. Global Vaccine Delivery Devices Market, Sub-Segmentation Of Microneedle Patches And Microinjectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Dissolvable Microneedles
  • Solid Microneedles
  • Microinjector Devices

7. Vaccine Delivery Devices Market Regional And Country Analysis

  • 7.1. Global Vaccine Delivery Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Vaccine Delivery Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Vaccine Delivery Devices Market

  • 8.1. Asia-Pacific Vaccine Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Vaccine Delivery Devices Market, Segmentation By Type Of Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Vaccine Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Vaccine Delivery Devices Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Vaccine Delivery Devices Market

  • 9.1. China Vaccine Delivery Devices Market Overview
  • 9.2. China Vaccine Delivery Devices Market, Segmentation By Type Of Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Vaccine Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Vaccine Delivery Devices Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Vaccine Delivery Devices Market

  • 10.1. India Vaccine Delivery Devices Market, Segmentation By Type Of Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Vaccine Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Vaccine Delivery Devices Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Vaccine Delivery Devices Market

  • 11.1. Japan Vaccine Delivery Devices Market Overview
  • 11.2. Japan Vaccine Delivery Devices Market, Segmentation By Type Of Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Vaccine Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Vaccine Delivery Devices Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Vaccine Delivery Devices Market

  • 12.1. Australia Vaccine Delivery Devices Market, Segmentation By Type Of Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Vaccine Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Vaccine Delivery Devices Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Vaccine Delivery Devices Market

  • 13.1. Indonesia Vaccine Delivery Devices Market, Segmentation By Type Of Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Vaccine Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Vaccine Delivery Devices Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Vaccine Delivery Devices Market

  • 14.1. South Korea Vaccine Delivery Devices Market Overview
  • 14.2. South Korea Vaccine Delivery Devices Market, Segmentation By Type Of Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Vaccine Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Vaccine Delivery Devices Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Vaccine Delivery Devices Market

  • 15.1. Western Europe Vaccine Delivery Devices Market Overview
  • 15.2. Western Europe Vaccine Delivery Devices Market, Segmentation By Type Of Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Vaccine Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Vaccine Delivery Devices Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Vaccine Delivery Devices Market

  • 16.1. UK Vaccine Delivery Devices Market, Segmentation By Type Of Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Vaccine Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Vaccine Delivery Devices Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Vaccine Delivery Devices Market

  • 17.1. Germany Vaccine Delivery Devices Market, Segmentation By Type Of Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Vaccine Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Vaccine Delivery Devices Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Vaccine Delivery Devices Market

  • 18.1. France Vaccine Delivery Devices Market, Segmentation By Type Of Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Vaccine Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Vaccine Delivery Devices Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Vaccine Delivery Devices Market

  • 19.1. Italy Vaccine Delivery Devices Market, Segmentation By Type Of Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Vaccine Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Vaccine Delivery Devices Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Vaccine Delivery Devices Market

  • 20.1. Spain Vaccine Delivery Devices Market, Segmentation By Type Of Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Vaccine Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Vaccine Delivery Devices Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Vaccine Delivery Devices Market

  • 21.1. Eastern Europe Vaccine Delivery Devices Market Overview
  • 21.2. Eastern Europe Vaccine Delivery Devices Market, Segmentation By Type Of Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Vaccine Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Vaccine Delivery Devices Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Vaccine Delivery Devices Market

  • 22.1. Russia Vaccine Delivery Devices Market, Segmentation By Type Of Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Vaccine Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Vaccine Delivery Devices Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Vaccine Delivery Devices Market

  • 23.1. North America Vaccine Delivery Devices Market Overview
  • 23.2. North America Vaccine Delivery Devices Market, Segmentation By Type Of Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Vaccine Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Vaccine Delivery Devices Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Vaccine Delivery Devices Market

  • 24.1. USA Vaccine Delivery Devices Market Overview
  • 24.2. USA Vaccine Delivery Devices Market, Segmentation By Type Of Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Vaccine Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Vaccine Delivery Devices Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Vaccine Delivery Devices Market

  • 25.1. Canada Vaccine Delivery Devices Market Overview
  • 25.2. Canada Vaccine Delivery Devices Market, Segmentation By Type Of Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Vaccine Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Vaccine Delivery Devices Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Vaccine Delivery Devices Market

  • 26.1. South America Vaccine Delivery Devices Market Overview
  • 26.2. South America Vaccine Delivery Devices Market, Segmentation By Type Of Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Vaccine Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Vaccine Delivery Devices Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Vaccine Delivery Devices Market

  • 27.1. Brazil Vaccine Delivery Devices Market, Segmentation By Type Of Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Vaccine Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Vaccine Delivery Devices Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Vaccine Delivery Devices Market

  • 28.1. Middle East Vaccine Delivery Devices Market Overview
  • 28.2. Middle East Vaccine Delivery Devices Market, Segmentation By Type Of Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Vaccine Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Vaccine Delivery Devices Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Vaccine Delivery Devices Market

  • 29.1. Africa Vaccine Delivery Devices Market Overview
  • 29.2. Africa Vaccine Delivery Devices Market, Segmentation By Type Of Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Vaccine Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Vaccine Delivery Devices Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Vaccine Delivery Devices Market Competitive Landscape And Company Profiles

  • 30.1. Vaccine Delivery Devices Market Competitive Landscape
  • 30.2. Vaccine Delivery Devices Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Novartis International AG Overview, Products and Services, Strategy and Financial Analysis

31. Vaccine Delivery Devices Market Other Major And Innovative Companies

  • 31.1. AstraZeneca PLC
  • 31.2. 3M Company
  • 31.3. GlaxoSmithKline plc
  • 31.4. Moderna Inc.
  • 31.5. Becton Dickinson and Company (BD)
  • 31.6. Sinovac Biotech Co. Ltd.
  • 31.7. CSL Limited
  • 31.8. INOVIO Pharmaceuticals Inc.
  • 31.9. Terumo Corporation
  • 31.10. SCHOTT AG
  • 31.11. Serum Institute of India Pvt. Ltd.
  • 31.12. Bavarian Nordic A/S
  • 31.13. Dynavax Technologies Corporation
  • 31.14. CanSino Biologics Inc.
  • 31.15. Vaxxas Inc.

32. Global Vaccine Delivery Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Vaccine Delivery Devices Market

34. Recent Developments In The Vaccine Delivery Devices Market

35. Vaccine Delivery Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Vaccine Delivery Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Vaccine Delivery Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Vaccine Delivery Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer